Cargando…
Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspective
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy that is usually diagnosed at an advanced stage when curative surgery is no longer an option. Robust diagnostic biomarkers with high sensitivity and specificity for early detection are urgently needed. Systems biology provides a powerful...
Autores principales: | Zhang, Wu-Hu, Wang, Wen-Quan, Han, Xuan, Gao, He-Li, Li, Tian-Jiao, Xu, Shuai-Shuai, Li, Shuo, Xu, Hua-Xiang, Li, Hao, Ye, Long-Yun, Lin, Xuan, Wu, Chun-Tao, Long, Jiang, Yu, Xian-Jun, Liu, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710502/ https://www.ncbi.nlm.nih.gov/pubmed/33304458 http://dx.doi.org/10.1016/j.csbj.2020.11.018 |
Ejemplares similares
-
Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma
por: Tong, Yexin, et al.
Publicado: (2022) -
Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumors
por: Zhang, Wu-Hu, et al.
Publicado: (2020) -
The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma
por: Zhang, Jingchang, et al.
Publicado: (2022) -
Neutrophil Extracellular Traps and Macrophage Extracellular Traps Predict Postoperative Recurrence in Resectable Nonfunctional Pancreatic Neuroendocrine Tumors
por: Xu, Shuai-Shuai, et al.
Publicado: (2021) -
Transcriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2021)